Норвешка -
Норвешки -
Statens legemiddelverk
alendronat sandoz 70 mg
sandoz - københavn - alendronatnatriumtrihydrat - tablett, filmdrasjert - 70 mg
Норвешка -
Норвешки -
Statens legemiddelverk
calcium-sandoz 500 mg
sandoz - københavn - kalsiumkarbonat / kalsiumlaktatglukonat - brusetablett - 500 mg
Норвешка -
Норвешки -
Statens legemiddelverk
candemox comp 16 mg / 12.5 mg
sandoz - københavn - kandesartancileksetil / hydroklortiazid - tablett - 16 mg / 12.5 mg
Норвешка -
Норвешки -
Statens legemiddelverk
candemox comp 8 mg / 12.5 mg
sandoz - københavn - kandesartancileksetil / hydroklortiazid - tablett - 8 mg / 12.5 mg
Норвешка -
Норвешки -
Statens legemiddelverk
candemox comp 32 mg / 12.5 mg
sandoz - københavn - kandesartancileksetil / hydroklortiazid - tablett - 32 mg / 12.5 mg
Норвешка -
Норвешки -
Statens legemiddelverk
rimactazid 150 mg / 75 mg
sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
edistride
astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillegg til andre legemidler til behandling av type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
forxiga
astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillegg til andre legemidler til behandling av type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
Норвешка -
Норвешки -
Statens legemiddelverk
allopurinol sandoz 100 mg
sandoz - københavn - allopurinol - tablett - 100 mg